Literature DB >> 1213960

Purified postheparin plasma lipoprotein lipase in primary hyperlipoproteinemias.

D Ganesan, R H Bradford, G Ganesan, W J McConathy, P Alaupovic, H B Bass.   

Abstract

Purified postheparin plasma lipoprotein lipase (LPL) of normolipidemic and primary hyperlipoproteinemic subjects was characterized by lipoprotein C polypeptide activation and specificity for triglycerides in chylomicrons and VLDL. Chromatography of normal LPL on Sephadex G-100 resulted in two protein peaks, LPLC-1 (activated by C-I but not C-II) and LPLC-II (activated by C-II but not C-I). LPL from type I hyperlipoproteinemic subjects was not activated by C-I and C-II activation was reduced to 40% of control. Hydrolysis of chylomicron and VLDL triglycerides was severely impaired. Although chromatography of type I LPL resulted in two protein peaks, the protein peak corresponding to LPLC-I did not exhibit lipolytic activity and LPLC-II was reduced to 50% of control in protein and enzyme specific activity. Type III LPL was normal in respect to LPLC-I while LPLC-II averaged 40% of control. Hydrolysis of chylomicron and VLDL was reduced to 50% and 10% of control, respectively. An etiological implication for LPLC-I and/or LPLC-II in type I and III hyperlipoproteinemias is suggested.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1213960     DOI: 10.1152/jappl.1975.39.6.1022

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  1 in total

1.  Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.

Authors:  M L Kashyap; L S Srivastava; C Y Chen; C G Perisutti; M Campbell; R F Lutmer; C J Glueck
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.